Jump to content

Hebei Yuxing Bio-Engineering Co. Ltd

Add links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Entranced98 (talk | contribs) at 23:26, 5 November 2023 (Adding short description: "Chinese pharmaceutical company"). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Hebei Yuxing Bio-Engineering Co. Ltd is a Chinese active pharmaceutical ingredient (API) company that exports to the United States of America.[1] Recently, the US FDA issued a warning letter due to "evidence that the company was keeping incomplete documentation and did not adequately investigate instances of microbial contamination."[2]

References[edit]

  1. ^ Mezher, Michael (27 September 2016). "The Rooms Have Never Been Cleaned': Two New FDA Warning Letters for Chinese Manufacturers". RAPS. Retrieved 28 September 2016.
  2. ^ "Hebei Yuxing Bio-Engineering Co Ltd 9/6/16 - Warning Letter 320-16-31". US FDA. 6 September 2016. Retrieved 28 September 2016.


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Stub icon

This Chinese corporation or company article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Hebei_Yuxing_Bio-Engineering_Co._Ltd&oldid=1183696100"